Evaluation of aflatoxin contamination in crude medicinal plants used for the preparation of herbal medicine
- 15 Downloads
The medical focus is now on phytofoods, drugs and the consumption of medicinal plants is expanding worldwide. Safety and quality of herbal preparations is of great concern. Quality determines reproducible efficacy of herbal drugs and also safety is a concern both for public and health authorities in many countries specially developing ones. The reason attributed is that many contaminants and microbes that may cause quality deterioration and directly harm to the consumers, find entry in the crude herbal materials during collection and storage. The safety of these products is partially compromised due to the microbial presence, especially toxigenic fungi. The present study was designed to investigate the microbiological quality after storage of locally sold raw medicinal plants that were supplied to different pharma units involved in the preparation of herbal and various formulations of ayurvedic drugs. Twenty samples of raw medicinal plants were stored at room temperature for a year and subjected to microbiological evaluation and found that most of the samples loaded with bacterial and fungal contents, do not comply with the FDA regulations. The presence of aflatoxin gave signals of aflatoxin producing fungi i.e. A. flavus and A. parasiticus. So, there is an urgent need of making strategy to control the microbes during pre-harvest and post-harvest procedures. This study is an attempt to emphasize the need for consistent quality assessment of crude herbal drugs for safe therapeutic products suitable for human beings. Our findings may help in instituting public health standards towards production and safety of herbal drugs worldwide.
KeywordsAflatoxin Ayurveda Contamination Herbal medicine Microbial load Mycotoxin Public health
HC is thankful to UGC, New Delhi for providing Start up Grant fund.
HC conducted the laboratory work and fieldwork. PK prepared figure and writing. HC contributed to analysis of data. SY helped in writing, editing and preparation of manuscript.
Compliance with ethical standards
Conflict of interest
This manuscript described has not been published before; not under consideration for publication anywhere else; and has been approved by all co-authors.
- Application of immunoaffinity columns for sample cleanup prior to HPLC analysis for AFLAPREP® immunoaffinity column provided by R-RIBOPHARM RHONE LTD. www.r-biopharm.de
- Bhusan G, Agarwal A, Sharma SK (2018) Aflatoxin contamination of some common medicinal herbs. Med Plants 10(1):75–80Google Scholar
- Chandra H, Srivastava J, Agarwal RK (2016) Fundamental Techniques in Microbiology, Ist edn. John Publisher Pvt, Ltd, New DelhiGoogle Scholar
- EMAN (2003) European Mycotoxin Awareness Network co-ordinated by Leatherhead Food Research Association (UK). http://www.lfra.co.uk/eman/index.htm
- European Pharmacopoeia (2007) Microbiological quality of pharmaceutical preparations. Chapter 5.1.4, 6th edition. Strasbourg: EDQM 4451Google Scholar
- FAO (1997) Worldwide Regulations for Mycotoxins 1995. A compendium. FAO Food and Nutrition Paper No. 64. Rome, ItalyGoogle Scholar
- FDA (2015) Facts about the current good manufacturing practices (CGMPs). http://www.fda.gov/Drugs/DevelopmentApprovalProcess/Manufacturing/ucm169105.htm
- Holt JG, Krieg NR, Sneath PHA, Stanley JT, Williams ST (1994) Bergey’s manual of determinative bacteriology, 9th edn. Lippincott Williams and Wilkins Publications, BaltimoreGoogle Scholar
- IARC (International agency for research on cancer) (1993) Monographs on the evaluation of the carcinogenic risk of chemicals to humans: some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins, vol. 56. Lyon, pp 245–521Google Scholar
- Idu M, Erhabor JO, Idele SO (2011) Microbial load of some medicinal plants sold in local markets of Benin City, Nigeria. Int J Med Aromat Plants 1(3):272–277Google Scholar
- Kala CP (2011) Medicinal Plant and sustainable development. Nova Science Publishers, New York, USAGoogle Scholar
- Lange D (1997) Trade figures for botanical drugs world-wide. Medicinal Plant Conservation Newsletter 3:16–17Google Scholar
- Odedara OO, Memuletiwon EJ (2014) Microbial quality of some locally consumed herbal concoctions in Abeokuta Metropolis, Nigeria. J Nat Sci Eng Tech 13:58–66Google Scholar
- Pierce SE, Bell RL, Hellberg RS, Cheng C, Chen K, Williams-Hill DM, Martin WB, Allard MW (2012) Detection and identification of Salmonella enterica, Escherichia coli, and Shigella spp. via PCR-electrospray ionization mass spectrometry: isolate testing and analysis of food samples. Appl Environ Microbiol 78(23):8403–8411CrossRefGoogle Scholar
- Rajapandiyan K, Shanthi S, Vidya S (2013) Assessment of microbial quality in marketed herbal drugs sold in Trichy city. Int J Pharm Chem Biol Sci 3(3):894–898Google Scholar
- Raper KB, Fennel DP (1977) The genus Aspergillus. Krieger Publishing Company, New YorkGoogle Scholar
- Rodriguez-Amaya DB, Sabino M (2002) Mycotoxin research in Brazil: the last decade in review Braz. J Microbiol 33:1–11Google Scholar
- Saleem F, Sadia B, Awan FS (2017). Control of aflatoxin production using herbal plant extract. In: Aflatoxin Lukman Abdulra’Uf. IntechOpen. https://doi.org/10.5772/intechopen.69867. Available from: https://www.intechopen.com/books/aflatoxin-control-analysis-detection-and-health-risks/control-of-aflatoxin-production-using-herbal-plant-extract
- WHO (2000) General guidelines for methodologies on research and evaluation of traditional medicine. WHO, Geneva. http://whqlibdoc.who.int/hq/2000/WHO_EDM_TRM_2000.1.pdf
- WHO (2007) WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. http://apps.who.int/medicinedocs/index/assoc/s14878e/s14878e.pdf. Accessed 21 Feb 2014